Precipio, Inc. (PRPO)

USD 7.32

(15.26%)

Long Term Debt Summary of Precipio, Inc.

  • Precipio, Inc.'s latest annual long term debt in 2023 was 106 Thousand USD , down -86.34% from previous year.
  • Precipio, Inc.'s latest quarterly long term debt in 2024 Q1 was 99 Thousand USD , down -6.6% from previous quarter.
  • Precipio, Inc. reported annual long term debt of 776 Thousand USD in 2022, down -23.62% from previous year.
  • Precipio, Inc. reported annual long term debt of 1.01 Million USD in 2021, up 78.25% from previous year.
  • Precipio, Inc. reported quarterly long term debt of 92 Thousand USD for 2024 Q2, down -7.07% from previous quarter.
  • Precipio, Inc. reported quarterly long term debt of 597 Thousand USD for 2023 Q3, down -9.55% from previous quarter.

Annual Long Term Debt Chart of Precipio, Inc. (2023 - 1999)

Historical Annual Long Term Debt of Precipio, Inc. (2023 - 1999)

Year Long Term Debt Long Term Debt Growth
2023 106 Thousand USD -86.34%
2022 776 Thousand USD -23.62%
2021 1.01 Million USD 78.25%
2020 570 Thousand USD -10.09%
2019 634 Thousand USD 55.39%
2018 408 Thousand USD -86.13%
2017 2.94 Million USD -28.71%
2016 4.12 Million USD 1001.05%
2015 374.82 Thousand USD -94.92%
2014 7.37 Million USD 44.47%
2013 5.1 Million USD 0.0%
2012 - USD -100.0%
2011 4.93 Million USD -42.86%
2010 8.64 Million USD 0.0%
2009 - USD 0.0%
2008 - USD 0.0%
2007 - USD 0.0%
2006 - USD 0.0%
2005 - USD -100.0%
2004 2.19 Million USD 0.0%
2003 - USD -100.0%
2002 1.49 Million USD 0.0%
2001 - USD 0.0%
2000 - USD -100.0%
1999 12.53 Million USD 0.0%

Peer Long Term Debt Comparison of Precipio, Inc.

Name Long Term Debt Long Term Debt Difference
Aclaris Therapeutics, Inc. 3.07 Million USD 96.552%
Biodesix, Inc. 35.22 Million USD 99.699%
bioAffinity Technologies, Inc. 1.11 Million USD 90.523%
Castle Biosciences, Inc. 14.19 Million USD 99.253%
DarioHealth Corp. 24.59 Million USD 99.569%
Exact Sciences Corporation 2.47 Billion USD 99.996%
IDEXX Laboratories, Inc. 622.88 Million USD 99.983%
Illumina, Inc. 1.48 Billion USD 99.993%
Intelligent Bio Solutions Inc. 81.32 Thousand USD -30.343%
iSpecimen Inc. 29.13 Thousand USD -263.886%
Standard BioTools Inc. 3.98 Million USD 97.339%
23andMe Holding Co. 67.84 Million USD 99.844%
Medpace Holdings, Inc. 142.12 Million USD 99.925%
NeoGenomics, Inc. 606.06 Million USD 99.983%
Inotiv, Inc. 399.4 Million USD 99.973%
Psychemedics Corporation 945 Thousand USD 88.783%
Prenetics Global Limited 867.21 Thousand USD 87.777%
RadNet, Inc. 812.06 Million USD 99.987%
Sotera Health Company 2.22 Billion USD 99.995%
Star Equity Holdings, Inc. 1.14 Million USD 90.742%
Exagen Inc. 19.23 Million USD 99.449%
Natera, Inc. 282.94 Million USD 99.963%
Aspira Women's Health Inc. 1.43 Million USD 92.587%
Neogen Corporation 888.39 Million USD 99.988%
Myriad Genetics, Inc. 130.9 Million USD 99.919%
ICON Public Limited Company 3.66 Billion USD 99.997%
Bionano Genomics, Inc. 7.17 Million USD 98.523%
CareDx, Inc 28.27 Million USD 99.625%
Check-Cap Ltd. - USD -Infinity%
Twist Bioscience Corporation 79.17 Million USD 99.866%
Guardant Health, Inc. 1.13 Billion USD 99.991%
BioNexus Gene Lab Corp. 98.76 Thousand USD -7.328%
Fulgent Genetics, Inc. 10.11 Million USD 98.952%
Sera Prognostics, Inc. 840 Thousand USD 87.381%
OPKO Health, Inc. 222.03 Million USD 99.952%
Personalis, Inc. 1.23 Million USD 91.41%
Applied DNA Sciences, Inc. 739.16 Thousand USD 85.659%
Star Equity Holdings, Inc. 1.14 Million USD 90.742%
MDxHealth SA 35.56 Million USD 99.702%
Prenetics Global Limited 867.21 Thousand USD 87.777%
ENDRA Life Sciences Inc. 192.06 Thousand USD 44.809%
Mainz Biomed B.V. 2.19 Million USD 95.173%
Trinity Biotech plc 54.65 Million USD 99.806%
Neuronetics, Inc. 59.28 Million USD 99.821%
bioAffinity Technologies, Inc. 1.11 Million USD 90.523%